You searched for Antibody candidate - Page 52 of 69

News and Trends 31 May 2018

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

…a grant of £556K (€633K) from Innovate UK to develop its antibody platform, KnotBody, for therapeutic applications in chronic pain management. Iontas’ antibody approach could provide an alternative to opioids,…

May 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Nov 2022

CatalYm raises €50M to boost solid tumors trial

…GDFATHER-2 trial (GDF-15 antibody-mediated human effector cell relocation phase 2). The study evaluates visugromab in combination with an anti-PD1 antibody in patients with advanced solid tumors that are relapsed/refractory to…

November 22, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 24 Dec 2018

Looking Back on 2018: Our 10 Most Popular Interviews

…The company has a number of candidate drugs in its pipeline targeting various cancers and inflammatory diseases. Its current lead candidate is a monoclonal antibody targeting the antigen CD19. Morphosys…

December 24, 2018 - 8 minutesmins - By Helen Albert

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

…an ongoing collaboration with the Menarini group (Italy) for therapeutic development. Covered by the deal are candidates like OBT357, for acute myeloid leukemia (AML), and OX002, an antibody-drug conjugate targeting…

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

Trevor Baglin XO1 SuperX Virtual Biotech

Interview 19 Jun 2017

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

…A patient presented at my hospital with what’s called a paraprotein, which is sort of a rogue antibody produced by the aging immune system. This antibody targeted exosite 1 of…

June 19, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2018

The 5 Best-Selling European Drugs of 2017

…in 2000. Once hailed as a wonder drug, trastuzumab is a monoclonal antibody that recognizes the HER2/neu receptor that is highly expressed in about 20% of breast and gastric cancers….

April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…Valora’s immunotherapies look much like a conventional antibody, but with one of the usual Y-like arms replaced with a lectin domain. While the antibody domain provides precise targeting to specific…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

tumor cancer immunotherapy alderaan biotech

News and Trends 9 Jan 2020

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

…lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to…

January 9, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 3 Dec 2015

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

…at the same time and increase drastically the neutralizing capacity of these antibodies compared to monoclonal antibodies. The kinoids induce a natural antibody response against the targeted protein Fighting lupus…

December 3, 2015 - 4 minutesmins - By Joachim Eeckhout

medical cancer checkpoint inhibitor immunotherapy

News and Trends 29 Apr 2021

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

…inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These promising results did more than…

April 29, 2021 - 5 minutesmins - By Mark Zipkin

Infographics 19 Jan 2017

Infographic: A History of Approved Therapeutic Antibodies

…With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the…

January 19, 2017 - 1 minutemin - By Marie Godar

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

…the glycosylation patterns of antibodies reveals much more insights into disease progression than just looking at antibody levels. For instance, while the levels of a type of antibody known as…

January 19, 2022 - 5 minutesmins - By Sachin Rawat

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

CatalYm raises €50M to boost solid tumors trial

Looking Back on 2018: Our 10 Most Popular Interviews

UK Drug Discovery sells Cancer Target to German Pharma

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

The 5 Best-Selling European Drugs of 2017

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Infographic: A History of Approved Therapeutic Antibodies

Glycans Hit the Sweet Spot in Diagnostics

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!